Bank of New York Mellon Corp - TENAX THERAPEUTICS INC ownership

TENAX THERAPEUTICS INC's ticker is and the CUSIP is 88032L209. A total of 21 filers reported holding TENAX THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of TENAX THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$20,000
-60.0%
35,139
-1.2%
0.00%
Q4 2019$50,000
+16.3%
35,571
+0.0%
0.00%
Q3 2019$43,000
-12.2%
35,5700.0%0.00%
Q2 2019$49,000
-34.7%
35,570
-3.6%
0.00%
Q1 2019$75,000
+63.0%
36,911
-3.1%
0.00%
Q4 2018$46,00038,0770.00%
Other shareholders
TENAX THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of TENAX THERAPEUTICS INC shareholders